docShepherd
U.S. Antibiotic Awareness Week 2022 Focuses on Prevention https://www.cdc.gov/drugresistance/solutions-initiative/stories/USAAW-2022.html?ACSTrackingID=USCDC_426-DM93802&ACSTrackingLabel=Get%20ready%20for%20U.S.%20Antibiotic%20Awareness%20Week!&deliveryName=USCDC_426-DM93802
Antibiotic Use in the United States, 2022 Update: Progress and Opportunities https://www.cdc.gov/antibiotic-use/stewardship-report/current.html
Implementation Resources for Nursing Homes | Antibiotic Use | CDC https://www.cdc.gov/antibiotic-use/core-elements/nursing-homes/implementation.html
blahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblah
Med Dir Report 11-2022 here Choosing Wisely – 15 things we should question Phase 3 guidance: GDR regulations · Non-traditional meds such as antihistamines, seizure meds, other CNS meds, when…
https://drive.google.com/file/d/1ZNRuN3V22PFXiRKX6iFD2M-LnNL_Zven/view
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372215/
https://drive.google.com/file/d/1ZMCFHECiT9jy1maADv6otw-KdXej6K9N/view
Therapeutic Management of Nonhospitalized Adults With COVID-19 Nonhospitalized Adults: Therapeutic Management | COVID-19 Treatment Guidelines (nih.gov) Ritonavir-Boosted Nirmatrelvir (Paxlovid) Recommendation The Panel recommends using nirmatrelvir 300 mg with ritonavir 100…
https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html